The Effect of Combination Statin, Acetylsalicylic Acid and Dutasteride Use on Prostate Cancer - a Sub Analysis of the REDUCE Trial
Sponsor study identifier
observational
8,231
1 country
1
Study Start
August 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
August 2011
Actual (reported)The purpose of this study is to assess whether there is any interaction between statins, acetylsalicylic acid (ASA) and dutasteride on protection from prostate cancer, the development of high grade prostate cancer, or lower urinary tract symptoms.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2011
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2011
Date type not reportedThis date has not been verified as actual or estimated.
August 2011
Actual (reported)August 26, 2011
Actual (reported)September 5, 2011
Actual (reported)Diagnosis of Prostate Cancer
The relative risk of prostate cancer development in REDUCE study participants treated with a combination of statins, acetylsalicylic acid and dutasteride.
4 years
Diagnosis of High Grade Prostate Cancer
4 years
Improvement of Lower Urinary Tract Symptoms
4 years
Participants of the REDUCE trial (negative prostate biopsy at baseline) who had at least one post-baseline prostate biopsy.
University Health Network
Toronto, Ontario, M5G 2M9, Canada
Specimens were retained as part of the REDUCE protocol, but no biospecimens are required for the current protocol.
Neil E Fleshner, MD MPH FRCSC
University Health Network, Toronto
8,231 participants (actual enrollment reported by the registry).
First Submitted
August 26, 2011
First Posted
September 5, 2011
Study Start
August 2011
Date type not reportedThis date has not been verified as actual or estimated.
Response of Patients on Surveillance for Prostate Cancer to Dutasteride
Contact the study team to confirm eligibility.
Study Completion
August 2011
Actual (reported)Last Updated
September 9, 2011
Record last verified: 2011-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: